COMMUNIQUÉS West-GlobeNewswire

Beyond Air Announces $5.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
14/01/2026
GARDEN CITY, N.Y., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of [...]
Oragenics to Present at the 2026 Sequire Investor Summit in Puerto Rico
14/01/2026
Sarasota, Fla., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN) (“the “Company”) today announced that it will be presenting at the upcoming Sequire Investor Summit 2026. The fourth edition of the [...]
Solid Biosciences Provides 2026 Outlook Underscoring Neuromuscular and Cardiac Pipeline Momentum and Expanded Access to Next-Generation Capsid AAV-SLB101
13/01/2026
- Duchenne: Dosed 33 participants in the Phase 1/2 INSPIRE DUCHENNE clinical trial as of January 9, 2026; SGT-003 continues to be generally well tolerated using a steroid-only prophylactic immunomodulation regimen - - [...]
INVO Fertility to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026
13/01/2026
SARASOTA, Fla., Jan. 13, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility [...]
Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium
13/01/2026
WATERTOWN, Mass., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Foghorn ® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting [...]
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
13/01/2026
SOUTH SAN FRANCISCO, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc., or BBOT (NASDAQ: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today [...]
Kaneka Medical America LLC Announces U.S. Launch of WaveSelect 1014 Guidewire
13/01/2026
Exclusive U.S. Distribution Partnership with Enlight Medical Ltd. Enables Kaneka Medical America LLC to Bring Novel Neurovascular Guidewire Technology to the U.S. Market NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- [...]
Southern Pain and Spine Specialists Announces Dr. Ammar Alamarie, MD Named Castle Connolly Top Doctor for Pain Management in 2025 for Second Consecutive Year
13/01/2026
Dr. Ammar Alamarie’s second consecutive Castle Connolly Top Doctor honor for Pain Management, recognizing his clinical excellence, leadership, and compassionate, innovative patient-centered care nationwide. Matthews, NC [...]
Metabo Drops Examined: Is It Legit for Weight Loss? Safety Checks and Consumer Analysis 2026
13/01/2026
New York, NY, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Consumer interest in supplement legitimacy continues to rise as transparency becomes a deciding factor in purchasing decisions. Searches that include phrases such as “Is [...]
SPINEWAY : 2025 revenue of €12.4 million, with an acceleration of sales in Q4 2025 (+34%)
13/01/2026
Ecully, January 13, 2026 – 6:30 p.m. SPINEWAY 2025 revenue of €12.4 million, with an acceleration of sales in Q4 2025 (+34%) In thousands of euros 2025 2024 Change as a % H1 revenue 5,573 6,535 -15% H2 revenue 6,857 5, [...]
SPINEWAY : Chiffre d’affaires annuel 2025 de 12,4 ME avec une accélération des ventes au T4 2025 (+34%)
13/01/2026
Ecully, le 13 janvier 2026 – 18h30 SPINEWAY Chiffre d’affaires annuel 2025 de 12,4 M€ avec une accélération des ventes au T4 2025 (+34%) En milliers d’euros 2025 2024 Variation en % CA 1 er semestre 5 573 6 535 - 15% CA [...]
U.S. FDA grants Ipsen’s IPN60340 (ICT01) Breakthrough Therapy Designation in first line unfit Acute Myeloid Leukemia
13/01/2026
Breakthrough Therapy Designation granted for investigational therapy IPN60340 in combination with venetoclax and azacitidine in first line unfit acute myeloid leukemia PARIS, FRANCE, 13 JANUARY 2026 - Ipsen (Euronext: [...]
Stead Impact Ventures Leads $15M Series A to Support MedWatch Technologies’ Mission to Advance Metabolic Wellness Innovation
14/01/2026
LAS VEGAS, Jan. 14, 2026 (GLOBE NEWSWIRE) -- MedWatch Technologies today announced that Stead Impact Ventures has committed to lead its $15M Series A financing, supporting the company’s mission to advance metabolic [...]
EMJX CEO Eric Jackson to Host Fireside Chat on EMJX Treasury OS Strategy and Governance on January 22nd
14/01/2026
NORTH PALM BEACH, Fla., Jan. 14, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") and EMJ Crypto Technologies (“EMJX”), a digital-asset treasury operating platform with which the [...]
SCIENTURE Announces Issuance of Orange Book-Listable Patent Covering REZENOPY™, the Highest Dosage Naloxone HCl Nasal Spray Approved by the FDA for Life-Saving Opioid Overdose Emergency Treatment
14/01/2026
U.S. Naloxone Market: ~$154 million in annual sales and 9.3 million units annually COMMACK, NY, Jan. 14, 2026 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a holding company for existing and planned [...]
24/7 Market News - Kraig Labs Set to Deliver Spider Silk Fiber Samples to Three Industry Partners
14/01/2026
Deliveries will Mark Its First Commercial Sales and the Start of the Spider Silk Race DENVER, Jan. 14, 2026 (GLOBE NEWSWIRE) -- 247marketnews.com , a pioneer in digital media dedicated to the swift distribution of [...]
Groundwork BioAg Expands in Brazil with Appointment of Roberto Gajardoni as Country Manager
14/01/2026
MAZOR, Israel , Jan. 14, 2026 (GLOBE NEWSWIRE) -- Groundwork BioAg ® (“Groundwork”), the world’s largest mycorrhizal inoculant producer, announced the appointment of Roberto Gajardoni as Brazil Country Manager, marking [...]
NDT Pharmaceuticals, Inc.’s Wholly Owned Subsidiary, Good Salt Life, Inc., to Launch Dog Gone Odor® on Chewy and Amazon, Expanding its Rapidly Growing Biosafety Catalog
14/01/2026
ATHENS, Ga., Jan. 14, 2026 (GLOBE NEWSWIRE) -- NDT Pharmaceuticals, Inc. (OTC: NDTP) ($NDTP), a leader in innovative health and wellness solutions, announces that its wholly owned subsidiary, Good Salt Life, Inc ., is [...]
Plus Therapeutics Announces Pricing of Upsized $15 Million Public Offering
14/01/2026
HOUSTON, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ: PSTV) (the “Company”), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous [...]

Pages

Other news

Test 2

22/10/2026

Lorem ipsum

Test 1

22/10/2026

Lorem upsum